Skip to main content
OpenTrials

Clinical trial condition

TDP-43 Proteinopathies

Explore clinical trials studying TDP-43 Proteinopathies. Study availability and eligibility vary by location and protocol.

872 public trials 213 recruiting studies
Refine in advanced search Browse all conditions

TDP-43 Proteinopathies trial results

Recruiting

A Study of LTX-002 in Adult Participants With Amyotrophic Lateral Sclerosis

NCT07660614

Conditions
Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +8 more
Locations
  • University Hospital Schleswig-Holstein, Campus Lübeck Lübeck, Germany
  • Istituto Neurologico "Carlo Besta" Milan, Italy
  • AOU Città della Salute e della Scienza di Torino Torino, Italy
  • Universitair Medisch Centrum Utrecht Utrecht, Netherlands
View Trial Details
Recruiting

A Study to Evaluate the Safety and Effect of AVB-101, a Gene Therapy Product, in Subjects With a Genetic Sub-type of Frontotemporal Dementia (FTD-GRN)

NCT06064890

Conditions
Aphasia, Aphasia, Primary Progressive, Brain Diseases, +22 more
Locations
  • The Ohio State University (OSU) Wexner Medical Center Columbus, Ohio, United States
  • Vanderbilt University Medical Centre Nashville, Tennessee, United States
  • Houston Methodist Hospital Houston, Texas, United States
  • UZ Leuven Leuven, Belgium
View all 19 locations
View Trial Details
Recruiting

Pridopidine Phase 3 Study to Evaluate Efficacy and Safety in ALS

NCT07322003

Conditions
Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +8 more
Locations
  • California Pacific Medical Center San Francisco, California, United States
  • Mayo Clinic Jacksonville, Florida, United States
  • University of South Florida Tampa, Florida, United States
  • Emory University Atlanta, Georgia, United States
View all 56 locations
View Trial Details

Related conditions